Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation-Reference-Cited by-同舟云学术

Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantation

Published:2022-11-11 Issue:2 Volume:58 Page:602-605
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatric Pulmonology

Author:

Ørum Matilde B.¹^ORCID,Rönsholt Frederikke F.²³,Jeppesen Majbritt¹⁴,Bendstrup Elisabeth⁴⁵,Katzenstein Terese L.³,Ott Peter⁴⁶,Perch Michael²⁷,Pressler Tacjana³,Qvist Tavs³,Jensen‐Fangel Søren¹⁴

Affiliation:

1. Department of Infectious Diseases, Cystic Fibrosis Clinic Aarhus University Hospital Aarhus Denmark

2. Department of Cardiology, Section for Lung Transplantation University Hospital Rigshospitalet Copenhagen Kobenhavn Denmark

3. Department of Infectious Diseases, Cystic Fibrosis Clinic University Hospital Rigshospitalet Copenhagen Kobenhavn Denmark

4. Institute of Clinical Medicine Aarhus University Aarhus Denmark

5. Department of Respiratory Diseases and Allergy, Center for Rare Lung Diseases Aarhus University Hospital Aarhus Denmark

6. Department of Hepatology and Gastroenterology Aarhus University Hospital Aarhus Denmark

7. Department Clinical Medicine University of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.26217

Reference5 articles.

1. Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients

2. The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series

3. CFTR modulator use in post lung transplant recipients

4. CFTR modulator therapy in patients with cystic fibrosis and an organ transplant

5. Ivacaftor-elexacaftor-tezacaftor and tacrolimus combination in cystic fibrosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant;Current Opinion in Pulmonary Medicine;2024-08-01

2. Safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with Cystic Fibrosis following liver transplantation: A systematic review;Journal of Cystic Fibrosis;2024-05

3. Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug–Drug Interactions between Elexacaftor/Tezacaftor/Ivacaftor and Tacrolimus in Lung Transplant Recipients;Pharmaceutics;2023-05-08

4. Position paper: Models of post-transplant care for individuals with cystic fibrosis;Journal of Cystic Fibrosis;2023-05

5. Use of CFTR modulators in special populations, part 3: Solid organ transplant;Pediatric Pulmonology;2023-04-17